Sandbox:Mitra: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{familytree/start}} | {{familytree/start}} | ||
{{familytree | | | | | | | | | | | | | A01 | | | | | | | | | | |A01= <div style="float: Center; text-align: Center; width: 20em; padding:1em;"> '''Therapuetic Considerations in [[RVMI]]'''| | | |}} | {{familytree | | | | | | | | | | | | | A01 | | | | | | | | | | |A01= <div style="float: Center; text-align: Center; width: 20em; padding:1em;"> '''Therapuetic Considerations in [[Right Ventriculay Myocardial Infarction]] ([[RVMI]]'''| | | |}} | ||
{{familytree | | | | | | | | | | || | |!| | | | | | | | | | | | | | |}} | {{familytree | | | | | | | | | | || | |!| | | | | | | | | | | | | | |}} | ||
{{familytree | | | |,|-|-|-|-|v|-|-|-|-|+|-|-|-|v|-|-|-|v|-|-|-|-|.| |}} | {{familytree | | | |,|-|-|-|-|v|-|-|-|-|+|-|-|-|v|-|-|-|v|-|-|-|-|.| |}} | ||
{{familytree | | | |!| | | | |!| | | | |!| | | |!| | | |!| | | | |!| |}} | {{familytree | | | |!| | | | |!| | | | |!| | | |!| | | |!| | | | |!| |}} | ||
{{familytree | | | B01 | | | B02 | | | B03 | | B04 | | B05 | | | B06 |B01=<div style="float: Center; text-align: Center; width: 5em; padding:1em;">'''Reperfusion'''|B02=<div style="float: Center; text-align: Center; width: 5em; padding:1em;">'''Maintenance of [[RV]] [[preload]]'''|B03=<div style="float: center; text-align: center; width: 5em; padding:1em;">''' | {{familytree | | | B01 | | | B02 | | | B03 | | B04 | | B05 | | | B06 |B01=<div style="float: Center; text-align: Center; width: 5em; padding:1em;">'''[[Reperfusion]]'''|B02=<div style="float: Center; text-align: Center; width: 5em; padding:1em;">'''Maintenance of [[RV]] [[preload]]'''|B03=<div style="float: center; text-align: center; width: 5em; padding:1em;">'''Decreasing [[RV]] [[afterload]]'''|B04=<div style="float: Center; text-align: Center; width: 5em; padding:1em;">'''Restoring [[Rate]]/[[Rhythm]] and [[AV synchrony]]'''|B05=<div style="float: Center; text-align: Center; width: 5em; padding:1em;">'''Inotropic support'''|B06=<div style="float: Center; text-align: Center; width: 5em; padding:1em;">'''[[Mechanical Circulatory Support]]'''}} | ||
{{familytree | | | |!| | | | |!| | | | |!| | | |!| | | |!| | | | |!| | | |}} | {{familytree | | | |!| | | | |!| | | | |!| | | |!| | | |!| | | | |!| | | |}} | ||
{{familytree | | | C01 | | | C02 | | | C03 | | C04 | | C05 | | | C06 |C01=<div style="float: Center; text-align: Center; width: 5em; padding:2em;"> •'''Thrmobolytics''' <br> •'''[[Percutaneous coronary intervention]] ([[PCI]])''' <br> | {{familytree | | | C01 | | | C02 | | | C03 | | C04 | | C05 | | | C06 |C01=<div style="float: Center; text-align: Center; width: 5em; padding:2em;"> •'''[[Thrmobolytics]]''' <br> •'''[[Percutaneous coronary intervention]] ([[PCI]])''' <br> | ||
|C02= <div style="float: Center; text-align: left;"> • '''Avoidance of preload-reducing agents''', such as:<br> | |C02= <div style="float: Center; text-align: left;"> • '''Avoidance of preload-reducing agents''', such as:<br> | ||
:❑ [[Nitrates]] | :❑ [[Nitrates]] | ||
Line 12: | Line 12: | ||
:❑ [[Morphin]] | :❑ [[Morphin]] | ||
• '''In patients with [[hypotension]] (without [[pulmonary congestion]]): | • '''In patients with [[hypotension]] (without [[pulmonary congestion]]): | ||
:❑ Intravenous administration of Fluids (N/S 0.9% at 40mL for 2L, to maintain [[CVP]] <15 mmHg and [[PCWP]] between 18-24 mmHg) | :❑ Intravenous administration of Fluids ([[N/S]] 0.9% at 40mL/min for 1-2L, to maintain [[CVP]] <15 mmHg and [[PCWP]] between 18-24 mmHg) | ||
|C03=<div style="float: Center; text-align: left;"> • '''Systemic or pulmonary [[vasodilators]]:'''<br> | |C03=<div style="float: Center; text-align: left;"> • '''Systemic or pulmonary [[vasodilators]]:'''<br> | ||
:❑ [[Nitrosrusside]] | :❑ [[Nitrosrusside]] |
Revision as of 16:05, 4 August 2020
Therapuetic Considerations in Right Ventriculay Myocardial Infarction (RVMI | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Inotropic support | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
• Avoidance of preload-reducing agents, such as: • In patients with hypotension (without pulmonary congestion): | • In patients with bradyarrhthmias: • In patients with atrioventricular block:
| • May be needed in patients with cardiogenic shock secondary to RVMI:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Do's
- Right ventricular myocardial infarction (RVMI) should be ruled out in all patients presenting with acute inferior wall myocardial infarction, in particular in patients with hypotension.
- In patients presenting with chest pain and clinical findings of hypotension, elevated JVP and clear lung fields, consider the differential diagnoses of RVMI. These include:
- Systemic or pulmonary vasodilators may be considered in selected patients to reduce RV afterload, thereby improving cardiac output.
- In patients with severe tricuspid regurgitation due to RVMI, replacement of tricuspid valve or repair of the valve with annuloplasty rings may be considered.
- In patients with RVMI who have unexplained hypoxemia despite administration of 100% oxygen, right-to-left shunting -through a patent foramen ovale or atrial septal defect-, caused by the disproportionate elevation in right-sided filling pressures compared to the normal or slightly increased left-sided filling pressures should be considered.
- Patients with extensive necrosis due to RVMI may be at higher risk of right ventricular perforation during interventional procedures. Right ventricular catheterization or pacemaker insertion should be performed with great care in these patients.
Don'ts
- In patients with RVMI, avoid preload-reducing agents such as nitrates, diuretics, morphine, beta-blockers, and calcium channel blockers.